Phalgun Nori, MD
Physical Medicine and Rehabilitation · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 4 carriers
- Offices
- 2
- Since medical school
- 21 years
- Graduated 2005
Offices
2 locations · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center · Stanford Health Care · 05t038. That is not proof they admit you there this week.
Plans that list them
23 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nori’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C174002 · Current
Licensed to practise in California · since 2021 · expires 2027-07-31 · University of West Indies Faculty of Medicine St Agustine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
2 licences
- Texas W8064Physician License · since 2026 · expires 2028-08-31Matched by name, not licence number; check the name before relying on it.ActiveNo board action on this licenceCheck it with the state
- New Jersey 25MA08726300Medical Doctor · since 2010 · expires 2023-06-30InactiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Physical Medicine and Rehabilitation - Brain Injury Medicine
- American Board of Physical Medicine and Rehabilitation - Physical Medicine and Rehabilitation
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$43,711
Medicare paid this office $43,711 for 189 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $16,479 | $71 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 94 | $11,317 | $43 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,440 | $155 |
| Hospital discharge day management, more than 30 minutes | 40 | $4,251 | $104 |
| Short return visit (20+ min) | 35 | $1,880 | $51 |
See all 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $16,479 | $71 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 94 | $11,317 | $43 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $5,440 | $155 |
| Hospital discharge day management, more than 30 minutes | 40 | $4,251 | $104 |
| Short return visit (20+ min) | 35 | $1,880 | $51 |
| Return visit (30+ min) | 13 | $1,288 | $81 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 18 | 22 | 31 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
189 Original Medicare patients in 2024. Average age 71 · Under 65 21% · 85 and older 14% · Women 49% · Also on Medicaid 39% · Health risk score 1.79. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 75% · Stroke 64% · Diabetes 39% · Coronary heart disease 34% · Depression 31% · Atrial fibrillation 29% · Chronic kidney disease 28% · Heart failure 23% · Dementia 22% · Cancer 15% · COPD 13%.
The office billed $431,180, Medicare allowed $55,790 and paid $43,711; for 671 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 189 | 671 | 71 | 1.79 | $431,180 | $43,711 |
| 2023 | 149 | 606 | 70 | 1.67 | $337,537 | $39,031 |
| 2022 | 142 | 455 | 67 | 1.51 | $319,338 | $35,454 |
| 2021 | 305 | 13,566 | 75 | 2.13 | $664,226 | $154,453 |
| 2020 | 319 | 9,452 | 76 | 2.02 | $600,707 | $140,860 |
| 2019 | 548 | 8,520 | 77 | 1.99 | $649,987 | $148,529 |
| 2018 | 737 | 5,404 | 77 | 1.83 | $641,815 | $141,554 |
| 2017 | 297 | 1,752 | 76 | 2.13 | $304,026 | $101,021 |
| 2016 | 728 | 2,574 | 78 | 1.85 | $410,976 | $138,753 |
| 2015 | 1,309 | 5,371 | 77 | 1.72 | $841,834 | $296,807 |
| 2014 | 1,252 | 5,615 | 77 | 1.61 | $866,926 | $298,514 |
| 2013 | 1,434 | 5,910 | 77 | 1.58 | $940,241 | $317,030 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 85 | $16,789 | $48 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $8,591 | $77 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,522 | $167 |
| Hospital discharge day management, more than 30 minutes | 32 | $3,588 | $112 |
| Short return visit (20+ min) | 33 | $1,757 | $53 |
2022: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 52 | $16,305 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,976 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,817 | $209 |
| Hospital discharge day management, more than 30 minutes | 24 | $2,748 | $114 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 43 | $2,598 | $41 |
| Short return visit (20+ min) | 29 | $1,700 | $57 |
2021: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $45,122 | $63 |
| Botox | 12 | $44,163 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $14,522 | $175 |
| Hospital discharge day management, more than 30 minutes | 53 | $5,067 | $94 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 17 | $4,525 | $146 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 129 | $4,354 | $33 |
| Muscle electrical test | 19 | $2,471 | $77 |
| Short return visit (20+ min) | 15 | $1,569 | $75 |
| Hospital discharge day management, 30 minutes or less | 15 | $950 | $63 |
2020: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 131 | $55,032 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 85 | $15,840 | $178 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 150 | $7,406 | $34 |
| Hospital discharge day management, more than 30 minutes | 52 | $4,941 | $91 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 12 | $3,126 | $142 |
| Muscle electrical test | 12 | $1,715 | $71 |
| Return visit (30+ min) | 13 | $1,466 | $86 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,164 | $65 |
2019: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 148 | $58,005 | $61 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 364 | $22,505 | $34 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $14,454 | $162 |
| Hospital discharge day management, more than 30 minutes | 67 | $6,210 | $90 |
| Return visit (30+ min) | 19 | $2,717 | $91 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 11 | $2,276 | $126 |
| Hospital discharge day management, 30 minutes or less | 32 | $1,984 | $62 |
2018: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 197 | $72,678 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 526 | $31,508 | $32 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $12,816 | $160 |
| Hospital discharge day management, more than 30 minutes | 58 | $5,135 | $89 |
| Hospital discharge day management, 30 minutes or less | 40 | $2,371 | $59 |
2017: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 179 | $68,643 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $13,084 | $164 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 157 | $12,332 | $32 |
| Hospital discharge day management, more than 30 minutes | 53 | $4,663 | $85 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,121 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $926 | $84 |
2016: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 299 | $79,175 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 505 | $30,926 | $32 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 89 | $15,685 | $165 |
| Hospital discharge day management, more than 30 minutes | 89 | $8,007 | $88 |
| Hospital discharge day management, 30 minutes or less | 48 | $2,876 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,350 | $112 |
2015: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 621 | $167,918 | $62 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 980 | $69,068 | $33 |
| Hospital discharge day management, more than 30 minutes | 260 | $24,587 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 117 | $20,587 | $170 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 63 | $7,320 | $113 |
| Hospital discharge day management, 30 minutes or less | 109 | $6,878 | $63 |
2014: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 554 | $157,744 | $60 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 980 | $79,102 | $33 |
| Hospital discharge day management, more than 30 minutes | 275 | $25,846 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 105 | $18,680 | $168 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 74 | $8,586 | $116 |
| Hospital discharge day management, 30 minutes or less | 104 | $6,397 | $61 |
2013: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 700 | $173,204 | $60 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 1,045 | $75,474 | $32 |
| Hospital discharge day management, more than 30 minutes | 248 | $23,205 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 103 | $17,987 | $168 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 132 | $15,528 | $114 |
| Hospital discharge day management, 30 minutes or less | 124 | $7,548 | $61 |
| Return visit (30+ min) | 14 | $1,432 | $84 |
Medicaid work
$173 in 2024
Medicaid paid $173 for 50 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 22 | $173 |
| Medication list documented in medical record (COA) | 15 | $0 |
| Short return visit (20+ min) | 13 | $0 |
| 2024 | 50 | 3 | 15 | $173 |
| 2023 | 282 | 2 | 56 | $3,474 |
| 2022 | 24 | 1 | 12 | $361 |
| 2021 | 127 | 2 | 14 | $4,904 |
| 2020 | 135 | 3 | 16 | $3,830 |
| 2019 | 31 | 1 | 16 | $648 |
| 2018 | 243 | 2 | 13 | $6,295 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 180 | $3,045 |
| Short return visit (20+ min) | 102 | $429 |
2022
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 24 | $361 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 112 | $4,670 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 15 | $234 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 106 | $3,829 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 14 | $1 |
| No documentation of pain assessment, reason not given | 15 | $0 |
2019
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 31 | $648 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 144 | $4,429 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 99 | $1,866 |
Drugs they prescribed that Part D paid
$12,965
Pharmacies billed $12,965 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
166 generic and fewer than 11 brand-name prescriptions · $12,965 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Baclofen | 11 | $157 | $14 |
| Atorvastatin | 15 | $90 | $6 |
Year by year
| 2024 | 188 | 40 | None | None | $12,965 |
| 2023 | 167 | 43 | 0% (0) | None | $8,770 |
| 2022 | 95 | 27 | 0% (0) | None | $8,715 |
| 2021 | 424 | 81 | None | None | $45,977 |
| 2020 | 531 | 86 | None | None | $42,420 |
| 2019 | 367 | 77 | None | None | $32,403 |
| 2018 | 474 | 80 | None | None | $38,589 |
| 2017 | 319 | 52 | None | 14% | $14,593 |
| 2016 | 370 | 70 | 5% (20) | None | $20,454 |
| 2015 | 749 | 172 | 14% (101) | None | $33,923 |
| 2014 | 785 | 169 | 11% (88) | None | $27,823 |
| 2013 | 913 | 203 | 13% (117) | 23% | $43,483 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Dantrolene | 12 | $1,911 | $159 |
| Baclofen | 21 | $1,269 | $60 |
| Atorvastatin | 12 | $128 | $11 |
2021: 10 drugs
| Baclofen | 15 | $701 | $47 |
| Gabapentin | 18 | $382 | $21 |
| Levetiracetam | 17 | $341 | $20 |
| Atorvastatin | 46 | $298 | $6 |
| Pantoprazole | 23 | $196 | $9 |
| Carvedilol | 14 | $109 | $8 |
| Amlodipine Besylate | 20 | $88 | $4 |
| Famotidine | 11 | $84 | $8 |
| Clopidogrel | 11 | $54 | $5 |
| Metformin | 11 | $35 | $3 |
2020: 16 drugs
| Enoxaparin | 19 | $8,873 | $467 |
| Eliquis | 12 | $5,670 | $472 |
| Gabapentin | 24 | $451 | $19 |
| Levetiracetam | 30 | $413 | $14 |
| Metoprolol | 13 | $312 | $24 |
| Hydralazine | 16 | $288 | $18 |
| Pantoprazole | 28 | $271 | $10 |
| Dexamethasone | 12 | $222 | $19 |
| Atorvastatin | 40 | $217 | $5 |
| Famotidine | 15 | $191 | $13 |
| Tamsulosin | 13 | $170 | $13 |
| Amlodipine Besylate | 34 | $152 | $4 |
| Losartan | 12 | $80 | $7 |
| Clopidogrel | 14 | $75 | $5 |
| Metoprolol | 13 | $53 | $4 |
| Metformin | 17 | $40 | $2 |
2019: 6 drugs
| Dantrolene | 13 | $1,054 | $81 |
| Atorvastatin | 36 | $345 | $10 |
| Famotidine | 12 | $114 | $9 |
| Pantoprazole | 11 | $78 | $7 |
| Amlodipine Besylate | 17 | $73 | $4 |
| Metformin | 14 | $63 | $5 |
2018: 12 drugs
| Eliquis | 11 | $4,693 | $427 |
| Atorvastatin | 54 | $480 | $9 |
| Levetiracetam | 24 | $380 | $16 |
| Dexamethasone | 12 | $199 | $17 |
| Gabapentin | 12 | $186 | $16 |
| Tamsulosin | 12 | $142 | $12 |
| Metoprolol | 16 | $138 | $9 |
| Pantoprazole | 19 | $123 | $6 |
| Amlodipine Besylate | 33 | $122 | $4 |
| Lisinopril | 18 | $98 | $5 |
| Carvedilol | 15 | $88 | $6 |
| Metformin | 20 | $70 | $4 |
2017: 7 drugs
| Atorvastatin | 30 | $303 | $10 |
| Tamsulosin | 11 | $228 | $21 |
| Levetiracetam | 12 | $176 | $15 |
| Pantoprazole | 18 | $107 | $6 |
| Famotidine | 13 | $74 | $6 |
| Amlodipine Besylate | 12 | $59 | $5 |
| Metformin | 11 | $40 | $4 |
2016: 8 drugs
| Enoxaparin | 11 | $3,899 | $354 |
| Atorvastatin | 33 | $257 | $8 |
| Levetiracetam | 15 | $157 | $10 |
| Metoprolol | 30 | $123 | $4 |
| Amlodipine Besylate | 30 | $108 | $4 |
| Clopidogrel | 15 | $82 | $5 |
| Lisinopril | 15 | $50 | $3 |
| Famotidine | 11 | $45 | $4 |
2015: 22 drugs
| Xarelto | 24 | $4,763 | $198 |
| Celecoxib | 12 | $844 | $70 |
| Atorvastatin | 52 | $347 | $7 |
| Oxycodone | 22 | $259 | $12 |
| Pravastatin | 15 | $240 | $16 |
| Oxycodone-Acetaminophen | 15 | $217 | $14 |
| Metoprolol | 19 | $200 | $11 |
| Pantoprazole | 28 | $164 | $6 |
| Tamsulosin | 11 | $149 | $14 |
| Metoprolol | 33 | $149 | $5 |
| Gabapentin | 13 | $138 | $11 |
| Levetiracetam | 11 | $134 | $12 |
| Amlodipine Besylate | 29 | $133 | $5 |
| Tramadol | 29 | $114 | $4 |
| Levothyroxine | 15 | $113 | $8 |
| Clopidogrel | 16 | $111 | $7 |
| Furosemide | 23 | $95 | $4 |
| Losartan | 19 | $87 | $5 |
| Famotidine | 18 | $75 | $4 |
| Lisinopril | 19 | $69 | $4 |
| Hydromorphone | 11 | $66 | $6 |
| Warfarin | 16 | $54 | $3 |
2014: 19 drugs
| Xarelto | 21 | $3,742 | $178 |
| Januvia | 12 | $1,837 | $153 |
| Atorvastatin | 41 | $435 | $11 |
| Metoprolol | 21 | $359 | $17 |
| Oxycodone-Acetaminophen | 20 | $227 | $11 |
| Pravastatin | 14 | $221 | $16 |
| Tamsulosin | 21 | $200 | $10 |
| Metoprolol | 41 | $196 | $5 |
| Amlodipine Besylate | 37 | $146 | $4 |
| Oxycodone | 16 | $146 | $9 |
| Tramadol | 28 | $137 | $5 |
| Levothyroxine | 17 | $122 | $7 |
| Pantoprazole | 20 | $120 | $6 |
| Furosemide | 26 | $106 | $4 |
| Losartan | 18 | $105 | $6 |
| Gabapentin | 16 | $98 | $6 |
| Lisinopril | 28 | $87 | $3 |
| Hydromorphone | 14 | $82 | $6 |
| Warfarin | 21 | $74 | $4 |
2013: 23 drugs
| Xarelto | 25 | $3,858 | $154 |
| Celebrex | 17 | $2,214 | $130 |
| Atorvastatin | 71 | $1,364 | $19 |
| Fentanyl | 12 | $1,059 | $88 |
| Oxycontin | 11 | $871 | $79 |
| Losartan | 28 | $450 | $16 |
| Hydralazine | 15 | $317 | $21 |
| Amlodipine Besylate | 56 | $240 | $4 |
| Oxycodone | 21 | $228 | $11 |
| Carvedilol | 24 | $197 | $8 |
| Lisinopril | 41 | $195 | $5 |
| Tamsulosin | 18 | $180 | $10 |
| Gabapentin | 15 | $167 | $11 |
| Metoprolol | 12 | $165 | $14 |
| Metoprolol | 31 | $157 | $5 |
| Simvastatin | 15 | $143 | $10 |
| Tramadol | 27 | $134 | $5 |
| Oxycodone-Acetaminophen | 23 | $130 | $6 |
| Hydromorphone | 17 | $121 | $7 |
| Pantoprazole | 13 | $96 | $7 |
| Levothyroxine | 16 | $83 | $5 |
| Warfarin | 22 | $66 | $3 |
| Furosemide | 15 | $38 | $3 |
Money from drug and device companies
$25 in 2025
| 2025 | 1 | 1 | None | $25 |
| 2021 | 1 | 1 | None | $17 |
| 2020 | 1 | 1 | None | $11 |
| 2019 | 10 | 13 | None | $247 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $25 | 1 payment
|
See the published payment
| Abbvie | Meals · 2025-10-29 | Botox | $25 |
See earlier years (2021, 2020, 2019)
2021: $17
| Merz Pharmaceuticals | Xeomin | $17 | 1 payment
|
2020: $11
| Vertical Pharmaceuticals | None | $11 | 1 payment
|
2019: $247
| Allergan | Botox | $108 | 3 payments
|
| Merz North America | Xeomin | $22 | 2 payments
|
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $20 | 1 payment
|
| Coloplast | Speedicath | $17 | 1 payment
|
| Ucb | Briviact | $15 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $14 | 1 payment
|
| Biogen | Spinraza | $14 | 1 payment
|
| Scilex Pharmaceuticals | Ztlido 30 Pouch in 1 Carton 1 Patch in 1 Pouch | $13 | 1 payment
|
| Collegium Pharmaceutical | Xtampza | $12 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $11 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| MERZ NORTH AMERICA, INC. · Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Investigate the Efficacy and Safety of Nt 201 in the Treatment of Lower Limb Spasticity Caused By Stroke Or Traumatic Brain Injury in Adult Subjects, Followed By An Open Label Extension With Or Without Combined Upper Limb Treatment · 2019 | This clinician | $1,451 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1043547656
- Licence
- CA C174002, NJ 25MA08726300California C174002: Current · expires 2027-07-31Texas W8064: ActiveNew Jersey 25MA08726300: Inactive
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2081P0301X (2081P0301X); Federal specialty code 208100000X (208100000X)
- Mailing address
- 1333 Moursund St, Houston, TX, 77030
- NPI first listed
- 2009-11-03
- NPI last updated
- 2026-08-19
- NPI record certified
- 2026-08-19
This is when the NPI record was last certified, not a medical board exam.